Seoul, South Korea – New research published July 1st indicates a link between inflammation during pregnancy and the growth of allergies in newborns, possibly mediated by the mother’s own glucocorticoid production. The study, appearing in the prestigious journal Mucosal Immunology, sheds light on the complex interplay between the maternal immune system and fetal development.
Scientists at the National research Foundation of South Korea, funded by the Ministry of Science and ICT through it’s Basic Research Program and Biomedical Technology Development Program, discovered that inflammation in the placenta triggers the formation of T cell memory. These memory T cells, in turn, appear to promote allergic responses in offspring. Crucially, this process is linked to endogenous glucocorticoids – hormones naturally produced by the mother’s body.
the research team, led by investigators at [Institution Name – *information not provided in original article, requires further research*], focused on the role of placental inflammation in shaping the immune system of the developing fetus. They found that inflammation during gestation doesn’t simply affect the immediate health of the baby, but can also “program” the immune system for a heightened allergic response later in life. Glucocorticoids,while typically known for their anti-inflammatory effects,appear to play a paradoxical role in this context,facilitating the establishment of these allergy-promoting T cell memories.
Allergic diseases, including asthma, eczema, and allergic rhinitis, are on the rise globally, with prevalence rates in South Korea estimated at over 30% in children. Understanding the prenatal origins of these conditions is vital for developing preventative strategies. This study suggests that managing maternal inflammation during pregnancy could be a potential avenue for reducing the risk of allergies in future generations.
The study utilized [Specific Model/Methodology – *information not provided in original article, requires further research*] to analyze immune cell populations in both mothers and their offspring. Researchers observed a correlation between higher levels of placental inflammation and increased numbers of specific T cell subsets in the newborns, which were associated with allergic sensitization. Further investigation is planned to determine the precise mechanisms by which glucocorticoids influence T cell memory formation in the placenta and the long-term consequences for offspring health.
This research builds upon a growing body of evidence highlighting the importance of the maternal microbiome and immune environment in shaping fetal development. Future studies will explore potential interventions, such as dietary modifications or targeted therapies, to modulate maternal inflammation and mitigate the risk of allergic diseases in children.The research team anticipates publishing follow-up studies within the next 12-18 months.
Copyright ⓒ Aju Press All rights reserved.
